This ASX All Ordinaries share shrugged off the red to reach a new 52-week high today

We take a look at an All Ordinaries share that outperformed the index, and itself, today.

| More on:
Four people on the beach leap high into the air.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points

  • ASX All Ordinaries healthcare share Ebos outperformed the index today 
  • The company's share price is trading at an all-time high 
  • The All Ordinaries Index slipped 0.89% in today's trade 

The All Ordinaries Index (ASX: XAO) fell 0.89% today. But this share bucked the trend to leap higher.

The Ebos Group Ltd (ASX: EBO) share price climbed 1.76% today to close at a yearly high $41.57.

Let's take a look at the Ebos Group in more detail.

What does this ASX All Ordinaries share do?

Ebos is a marketer, wholesaler and distributor of healthcare, medical, animal care and pharmaceutical products in Australia, New Zealand and South East Asia.

Healthcare represents 87% of the company's business, with the other 13% of the company devoted to animal care.

Ebos shares are currently trading at an all-time high.

In a recent investor presentation, Ebos highlighted it makes over 12 million deliveries a year to healthcare providers and end markets.

Ebos reported $10.7 billion in revenue in the 2022 financial year. While underlying net profit after tax (NPAT) lifted 21.3% to $228.2 million.

The company delivered a final dividend of NZ 49 cents per share in FY22. Overall in FY22, Ebos delivered 96 cents per share of dividends to investors, up 8.5% on the previous year.

Ebos has acquired 20 companies since 2014. In May, Ebos acquired LifeHealthcare, one of the largest medical device distributors in Australia, New Zealand and South East Asia. Ebos sees this acquisition as an expansion opportunity. Commenting on this acquisition in November, Ebos said: "The LifeHealthcare acquisition established our presence in Southeast Asia and opens other potential opportunities in the region."

Ebos share price snapshot

The Ebos share price has climbed 4.45% in the last year. Meanwhile, Ebos shares are up 8.54% year to date. The All Ords share has a market capitalisation of $7.78 billion.

For perspective, the ASX All Ordinaries Index has shed 8.2% in the past year and 7.48% in the year to date.

Motley Fool contributor Monica O'Shea has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Healthcare Shares

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

Why the Mesoblast share price is diving 18% after an FDA win

Investors are sending the Mesoblast share price tumbling on Friday. But why?

Read more »

A happy doctor in a white coat dancing due to his excitement over the EBOS acquisition
Healthcare Shares

Mesoblast share price rockets 30% on big US FDA news

Big news is giving this biotech a huge lift on Thursday.

Read more »

Two scientists in a Rhythm Biosciences lab cheer while looking at results on a computer.
Healthcare Shares

Guess which ASX healthcare stock is jumping 12% on Wednesday

This shares is rocketing this morning. But why? Let's find out.

Read more »

Man holding out Australian dollar notes, symbolising dividends.
Healthcare Shares

Here is the dividend forecast to 2029 for CSL shares

Can this blue-chip giant provide healthy dividend income?

Read more »

a doctor in a white coat makes a heart shape with his hands and holds it over his chest where his heart is placed.
Healthcare Shares

The best ASX 200 healthcare stocks to buy in 2025

These shares could give your portfolio a healthy boost next year according to Bell Potter.

Read more »

In the lab at work, the mature adult woman and young adult man smile as they review the results of their successful experimentation.
Healthcare Shares

ASX 300 healthcare stock lifts off on promising new results

Up 28% in a year, the ASX healthcare stock is leaping higher on Thursday.

Read more »

Doctor doing a telemedicine using laptop at a medical clinic
Healthcare Shares

If you'd invested $5,000 in this ASX 300 healthcare stock a year ago, you'd now have $30,000!

This stock has made millions for investors over just a few months.

Read more »

Male doctor in a lab coat working at laptop looking serious.
Healthcare Shares

Has the Pro Medicus share price risen too high too quickly?

Pro Medicus shares have rocketed 173% since this time last year.

Read more »